BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 853528)

  • 21. Hybrid cells derived from fusion of TA2-Ha ascites carcinoma with normal fibroblasts. II. Characterization of isoantigenic variant sublines.
    Friberg S; Klein G; Wiener F; Harris H
    J Natl Cancer Inst; 1973 May; 50(5):1269-86. PubMed ID: 4712591
    [No Abstract]   [Full Text] [Related]  

  • 22. Tumor-host cell hybrids in radiochimeras.
    Wiener F; Fenyö EM; Klein G
    Proc Natl Acad Sci U S A; 1974 Jan; 71(1):148-52. PubMed ID: 4521047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The stability of X-chromosome inactivation: studies with mouse-human cell hybrids and mouse teratocarcinomas.
    Kahan B
    Basic Life Sci; 1978; 12():297-328. PubMed ID: 752323
    [No Abstract]   [Full Text] [Related]  

  • 24. Suggestive evidence for functionally distinct, tumor-suppressor genes on chromosomes 1 and 11 for a human fibrosarcoma cell line, HT1080.
    Kugoh HM; Hashiba H; Shimizu M; Oshimura M
    Oncogene; 1990 Nov; 5(11):1637-44. PubMed ID: 2267132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inheritance of immunogenicity and metastatic potential in murine cell hybrids from the T-lymphoma ESb08 and normal spleen lymphocytes.
    Larizza L; Schirrmacher V; Stöhr M; Pflüger E; Dzarlieva R
    J Natl Cancer Inst; 1984 Jun; 72(6):1371-81. PubMed ID: 6610070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Segregation of chromosomes and DNA replication in intraspecific L X LS/BL hybrids.
    Nebola M; Spurná V; Kamenická E
    Folia Biol (Praha); 1981; 27(5):324-33. PubMed ID: 6895361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of tumorigenicity in somatic cell hybrids. III. Cosegregation of human chromosome 11 of a normal cell and suppression of tumorigenicity in intraspecies hybrids of normal diploid x malignant cells.
    Kaelbling M; Klinger HP
    Cytogenet Cell Genet; 1986; 41(2):65-70. PubMed ID: 3956263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic determinants of morphological differentiation in hybrid tumors.
    Wiener F; Cochran A; Klein G; Harris H
    J Natl Cancer Inst; 1972 Feb; 48(2):465-86. PubMed ID: 4652383
    [No Abstract]   [Full Text] [Related]  

  • 29. Proof of in vivo fusion of murine tumor cells with host cells by universal fusers.
    Ber R; Wiener F; Fenyö EM
    J Natl Cancer Inst; 1978 Apr; 60(4):931-3. PubMed ID: 633401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of tumorigenicity in somatic cell hybrids. IV. Chromosomes of normal human cells associated with suppression of tumorigenicity in hybrids with D98AH2 carcinoma cells.
    Klinger HP; Kaelbling M
    Cytogenet Cell Genet; 1986; 42(4):225-35. PubMed ID: 3463446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of human keratinocyte X HeLa somatic cell hybrids.
    Peehl DM; Stanbridge EJ
    Int J Cancer; 1981 May; 27(5):625-35. PubMed ID: 6169665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered differentiation, indefinite growth potential, diminished tumorigenicity, and suppressed chimerization potential of hybrids between mouse teratocarcinoma cells and thymocytes.
    Martin GM; Ogburn CE; Au K; Disteche CM
    J Exp Pathol; 1984; 1(2):103-33. PubMed ID: 6599936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fusion-induced malignancy? A preliminary study. (a challenge to today's common wisdom).
    Munzarová M; Lauerová L; Kovarík J; Rejthar A; Brezina V; Kellnerová R; Kovarík A
    Neoplasma; 1992; 39(2):79-86. PubMed ID: 1528312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathology of human-mouse somatic cell hybrid tumors.
    Aden DP; Putong P; Iwasaki Y
    J Natl Cancer Inst; 1977 Oct; 59(4):1243-9. PubMed ID: 198557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune response to somatic cell hybrids between ultraviolet radiation-induced regressor and spontaneous progressor C3H mouse tumor cells.
    Chen PW; Kaba DS; Ananthaswamy HN
    Cancer Res; 1990 Mar; 50(5):1544-9. PubMed ID: 2137370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A nontumorigenic (mouse X human) cell hybrid inhibits tumorigenicity of its malignant mouse parent cell and unrelated human tumor cells in vivo.
    Chopan M; Kopelovich L
    Oncology; 1981; 38(4):240-2. PubMed ID: 7243176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stable nontumorigenic phenotype of somatic cell hybrids between malignant Burkitt's lymphoma cells and autologous EBV-immortalized B cells despite induction of chromosomal breakage and loss.
    Jox A; Taquia E; Vockerodt M; Draube A; Pawlita M; Möller P; Bullerdiek J; Diehl V; Wolf J
    Cancer Res; 1998 Nov; 58(21):4930-9. PubMed ID: 9810002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid viral induction of murine lymphomas in the graft-versus-host reaction.
    Cornelius EA
    J Exp Med; 1972 Dec; 136(6):1533-44. PubMed ID: 4404880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppressor genes for malignant and anchorage-independent phenotypes located on human chromosome 9 have no dosage effects.
    Islam MQ; Islam K
    Cytogenet Cell Genet; 2000; 88(1-2):103-9. PubMed ID: 10773681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Somatic cell hybrids between totipotent mouse teratocarcinoma and rat hepatoma cells.
    Litwack G; Croce CM
    J Cell Physiol; 1979 Oct; 101(1):1-8. PubMed ID: 44296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.